MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this trial is to demonstrate non-inferiority of MENOPUR® versus recombinant Follicle Stimulating Hormone (rFSH) (Gonal-f®) with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation (COS) following GnRH treatment.
Epistemonikos ID: 9e4042f8755a86f589072d10f160e08a1eeb16ce
First added on: May 12, 2024